Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Grand House Mulia Tbk. (HOMI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Grand House Mulia Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Grand House Mulia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Grand House Mulia Tbk. trades at Rp232 (market cap 384.3B, 3.49M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and Grand House Mulia Tbk. is more actively traded (3.49M versus 635.5K). Which is the better fit depends on your goals.

HOMILABS
Market Cap
384.3B691.25B
Volume
3.49M635.5K
Lot
34.89K6.36K
Turnover
796.11M110.15M
Average Price
228.18173.33
Value
796.11M110.15M
Indicative Equilibrium Price
232174
Indicative Equilibrium Volume
11050

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HOMI
View details
LABS
View details

About Grand House Mulia Tbk.

PT Grand House Mulia, Tbk (“the Company”) was established in Republic of Indonesia based on the Notarial Deed No. 1 dated January 9, 2006 of Suryati Moerwibowo, S.H., The Company has commercially operated in April 2019.

Read more on HOMI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS